Skip NavigationSkip to Content
Return Return to Search Results

CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-alpha therapy and toll-like receptor 3 signalling

  1. Author:
    Katsounas, A.
    Trippler, M.
    Wang, B.
    Polis, M.
    Lempicki, R. A.
    Kottilil, S.
    Gerken, G.
    Schlaak, J. F.

  2. Author Address

    [Katsounas, A.; Trippler, M.; Wang, B.; Gerken, G.; Schlaak, J. F.] Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany. [Katsounas, A.; Lempicki, R. A.] NCI, Lab Immunopathogenesis & Bioinformat, SAIC Frederick Inc, Frederick, MD 21701 USA. [Polis, M.; Kottilil, S.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.;Schlaak, JF (reprint author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Hufelandstr 55, D-45122 Essen, Germany;joerg.schlaak@uni-due.de
    1. Year: 2012
    2. Date: Feb
  2. Journal: Journal of Viral Hepatitis
    1. 19
    2. 2
    3. Pages: 128-137
  4. Type of Article: Article
  5. ISSN: 1352-0504
  1. Abstract:

    FY2011-2012

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1111/j.1365-2893.2011.01503.x.
  3. View record in Web of Science®
  4. WOS: 000299097400035

Library Notes

  1. No notes added.
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel